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4. Microbiology 
~ Effect of nebuliser suspension solutions on survival of 
Pseudomonas aeruginosa (PA) within artificially generated 
aerosols 
I.J. Clifton 1 , L.A. Fletcher 2, C. Beggs 3, D.G. Peckham 1 , S.R Conway 1. 1Regional 
CF Unit, Seacrofl HosFital, 2Aerobiological Research Group, University of Leeds, 
3School of Engineering, Design and Technology, University of Bradjbrd, UK 
Aims: The aim of the study was to determine the effect of different suspension 
solutions on survival of PA within aerosols in a laminar flow aerobiological 
apparatus. 
Methods: Aerosols were generated using a Collison 3-jet nebuliser containing 
distilled water (DW), increasing concentrations of Ringer's solution (RS) and 
10% foetal bovine serum (FBS); inoculated with PA to give a concentration 
of 105 CFUmL 1. The aerosol was delivered into a laminar flow device under 
controlled conditions of temperature and relative humidity. The air was sampled 
using an Andersen 6-stage impactor containing nutrient agar plates. After overnight 
incubation, the number of colonies were counted. The count was corrected using 
positive-hole correction and the concentration of viable bacteria within the air 
sample was calculated. 
Results: Aerosols generated using 10% FBS resulted in significantly higher con- 
centrations ofviable PA within the air sample than DW or isotonic RS ()~ 2 P < 0.05). 
Aerosols generated with hypotonic solutions contained significantly less viable PA 
than either the aerosols generated using isotonic ()~ 2 P < 0.05) or hypertonic solution 
()~ 2 P < 0.05). There was no difference between the concentration of viable PA 
within the aerosols generated using either isotonic or hypertonic solutions ()~ 2 P NS). 
Conclusions: This study demonstrates that PA can survive within droplet nuclei 
in artificially generated aerosols and that the solution in which the bacteria re 
suspended is important for the survival of bacteria within the aerosol. This supports 
recent evidence that airborne dispersion may be important for the transmission of 
strains of PA between patients. 
$33 
~ Epidemiology of Burkholderia species infection at a large adult 
Cystic Fibrosis centre 
M.E. Dodd 1 , J.R. Govan 2, C.J. Doherty 2, A.K. Webb 1 , A.M. Jones 1 . 1Manchester 
Adult CF Centre, 2 University of Edinburgh, UK 
Introduction: We have recorded all cases of Burkholderia species infection at our 
centre since 1983. We have had a policy of microbiological surveillance for cross- 
infection with Burkholderia species at our CF centre since 1991 and all isolates are 
sent to a reference microbiology laboratory for strain typing. We introduced partial 
segregation i  1991 and full segregation i  1993 for CF patients with Burkholderia 
species infection. All isolates available in the repository were genomovar typed in 
2001, including retrospective typing of previously stored isolates. We have a policy 
of sending sputum for culture, including on selective cepacia media, at each clinic 
visit and for all inpatients tays. 
Methods: We reviewed the results of strain and genomovar typing of all available 
Burkholderia isolates at our centre from 1983~005. 
Results: The incidence/prevalence of infection between 1983 1990 was below 
5%/9% each year. There was a rise in incidence/prevalence between 1991 to 1994 
with a peak of 15.6%/31.2% in 1992. Following full segregation the incidence has 
fallen to below 3% for all but one year and the prevalence has gradually reduced 
to 9.3% in 2005. In the past 11 years since segregation there have been 6 cases 
of infection with epidemic strains and 13 with unique strains. In the past 6 years, 
there has been just 1 case of new infection with an epidemic strain and 9 cases of 
new infections with unique strains within the centre. 
Conclusions: Segregation has controlled spread of epidemic B. cenocepacia strains. 
Unique strains now account for the majority of new Burkholderia species infections 
at our centre. 
~Do transmissible strains of Pseudomonas aeruginosa influence 
morbidity and mortality for patients with CF? 
C.M. Smith 1 , A.K. Webb 1 , M.E. Dodd 1 , J. Morris 1 , J.R.W Govan 2, A.M. Jones 1 . 
1Manchester Adult Cystic Fibrosis Centre (MACFC), 2 University of Edinburgh, 
UK 
Introduction: We performed a 5-year prospective study of clinical outcome for CF 
patients infected with transmissible and sporadic strains of/~ aeruginosa. 
Methods: At MACFC, patients with/~ aeruginosa infection who required in-patient 
treatment during the last 6 months of 1999 were studied prospectively for 5 years 
from March 2000. Patients were grouped into those infected with sporadic (Gpl) 
and transmissible (Gp2) strains. Clinical outcome differences between the groups 
were compared by t-tests, Mann U Whitney tests and analyses of covariance. 
Results: 80 patients were studied, 52 in Gpl (30 male, 22 female) and 28 in Gp2 
(11 male, 17 female). There were no differences between the groups in mean 
%FEV1, %FVC, age or BMI at baseline. Over 5 years there were 9/4 and 4/1 
deaths/lung transplants in Gpl and Gp2 (P ns). 9 Gp 1 patients became super- 
infected with a transmissible strain of/~ aeruginosa. 2 Gp 1 patients acquired 
infection with Burkholderia species. 3 Gp 1 patients moved to another area and 
were lost to follow up. 
For Gp 1 in 25) and Gp 2 in 23) patients with 5 year survival data there were 
again no differences in mean %FEV1, %FVC, age or BMI at baseline. At 5-year 
follow-up, Gp 1 patients had fewer IV antibiotic days (mean (SD) 30.2 [21.5] v 57.6 
[33.8] days) (P 0.001), and fewer annual inpatient treatment days (median [range] 
8.8 [1.8, 53.2] v 22.4 [6.6, 112.2] days) (P 0.001) than Gp2 patients. There was 
no difference in annual number of clinic visits, annual change in mean %FEV1, 
%FVC or BMI between the two groups. 
Conclusion: Patients with CF infected with transmissible strains of/~ aeruginosa 
have an increase in morbidity but no increase in mortality above those infected with 
sporadic/~ aeruginosa strains. 
• Identification of genomovar status, virulence genes and 
genotyping of Burkholderia cepacia complex strains isolated 
from Brazilian CF patients 
K.M. Martins 1, L.VF. da Silva Filho 1 , A.F. Tateno 3, A.B.D. Rodrigues 3,
A.C.G.S. Azzuz 2, J.C. Rodrigues 1 , D.O. Garcia 2. 1pulmonology Unit, Instituto da 
C~ianca, University of Sdo Paulo Medical School, 2Bacteriology Section, Instituto 
Adoljb Lutz, Sdo Paulo, 3 Instituto de Medicina Tropical, USP, S~,o Paulo, Brazil 
Aims: To identify genomovar status, genotype and the presence of virulence genes 
among B. cepacia complex isolates obtained from CF patients attending our Centre. 
Methods: Sputum or oropharyngeal samples were obtained in all medical visits 
from 140 children with CF attending our Unit from 9/00 to 4/01 and 6/03 to 
6/04. Samples were cultivated in selective media including B. cepacia medium and 
bacterial identification obtained by automated system and additional biochemical 
tests. B. cepacia complex strains were submitted to DNA extraction and determina- 
tion of genomovars (I to VII) obtained by PCR reactions targeting recA gene and 
DNA sequencing. Virulence genes screened were cable pilus (cblA) and epidemic 
strain marker (esmR). Genotyping was performed by RAPD analysis of the whole 
bacterial genome. 
Results: 41 isolates ofB. cepacia complex were obtained from 21 CF patients. The 
PCR method identified genomovar status of 31/41 (75.6%) isolates. All results were 
confirmed by DNA sequencing. B cenocepacia was the main genomovar ( n 17), 
followed by B. multivorans ( n 11), B. vietnamiensis ( n 2) and B. cepacia (n 1). 
CblA gene was not identified, but esmR was found on 2 strains (unrelated pa- 
tients). Genotyping depicted 26 patterns, without identical patterns among different 
patients. 
Conclusions: The PCR method targeting specific recA amplification showed to be 
a reliable tool for genomovar determination. B  cenocepacia and B. multivorans 
were the most prevalent among our patients. Cross infection seems unlikely in our 
Unit. 
